Pharmacokinetics of propofol when given by intravenous infusion.

We have previously shown with i.v. bolus studies that the elimination of propofol is much slower than previously reported. Now we have studied the implications of this for prolonged i.v. infusion of propofol in seven patients who received continuous infusions of propofol for up to 9 h. Values of elimination half-life ranged from 13.1 to 44.7 h, systemic clearance from 1.02 to 1.63 l h-1 and volume of distribution from 1390 to 3940 l and these were similar to those obtained with bolus administration. The large volume of distribution is consistent with the high octanol/blood partition coefficient, which was found to be 72.0. Despite the very long elimination half-life, blood propofol concentrations appeared to approach steady state within 20 min rather than the 4-5 half-lives normally expected. This is because for this drug, which displays multicompartment pharmacokinetics, the rate of initial rise of blood concentrations is governed primarily by the very short distribution half-life of the drug. Therefore, the long elimination half-life of propofol is probably of little significance in designing infusions regimens, but the lower systemic clearance should be taken into account to avoid unwanted accumulation.

[1]  R. Farinotti,et al.  Pharmacokinetics and Protein Binding of Propofol in Patients with Cirrhosis , 1988, Anesthesiology.

[2]  S L Shafer,et al.  Pharmacokinetics and Pharmacodynamics of Propofol Infusions during General Anesthesia , 1988, Anesthesiology.

[3]  D. Morgan,et al.  Extended blood collection period required to define distribution and elimination kinetics of propofol. , 1988, British journal of clinical pharmacology.

[4]  E. Gepts,et al.  Disposition of Propofol Administered as Constant Rate Intravenous Infusions in Humans , 1987, Anesthesia and analgesia.

[5]  M. White,et al.  Pharmacokinetics of propofol in female patients. Studies using single bolus injections. , 1987, British journal of anaesthesia.

[6]  J. Sear,et al.  Disposition of propofol in patients undergoing surgery. A comparison in men and women. , 1986, British journal of anaesthesia.

[7]  P. Parkin,et al.  Severe hypertension and raised haematocrit: unusual presentation of Guillain-Barré syndrome. , 1985, Postgraduate medical journal.

[8]  S. Bryson Clinical Pharmacokinetics: Concepts and applications. , 1983 .

[9]  S. Gelman Disturbances in hepatic blood flow during anesthesia and surgery. , 1976, Archives of surgery.

[10]  M. Rowland,et al.  Disposition in male volunteers of a subanaesthetic intravenous dose of an oil in water emulsion of 14C-propofol. , 1988, Xenobiotica; the fate of foreign compounds in biological systems.

[11]  G. Plummer Improved method for the determination of propofol in blood by high-performance liquid chromatography with fluorescence detection. , 1987, Journal of chromatography.

[12]  H. Schwilden,et al.  Pharmacokinetic and pharmacodynamic modelling of propofol ('Diprivan') in volunteers and surgical patients. , 1985, Postgraduate medical journal.